ABOUT US
COMPANY PROFILE -
Founded in 2006 and located in Polymer industrial park of Zibo High-tech District, Zibo Qianhui Biological Technology Co., Ltd is a high-tech enterprise specialized in the fields of research, manufacturing and trade.
Qianhui is professional in manufacturing cyclodextrin and its derivatives which could be used as pharmacutical excipients , food & cosmetic additives etc.
Developed new type injectable excipient Betadex Sulfobutyl Ether Sodium independently and filled the gap in domestic market, our Betadex Sulfobutyl Ether Sodium is the first one to pass the technical evaluation with related preparations (Registration status “A”). CDE registration No.: F20180000620, USA FDA DMF No.: 29394.
Hydroxypropyl Beta Cyclodextrin has been widely used and approved by global markets. CDE registration No.: F20209990335 (Oral, Registration status is “A”) / F20180000146 (Oral) / F20180000895 (Injection), USA FDA DMF No.: 033403.
Insisting on innovation-driven development strategy, keeping market demand as central task, keeping doing finer and more professional, Qianhui has launched series of cyclodextrin derivatives, such as Hydroxypropyl Beta Cyclodextrin, Betadex Sulfobutyl Ether Sodium, Methyl Beta Cyclodextrin, Gamma Cyclodextrin, Hydroxypropyl Gamma Cyclodextrin and so on. Paralleling innovation and development, Qianhui also attaches importance to the protection of intellectual property rights. 3 invention patents and 16 utility model patents have been authorized until now.
Science and Technological innovation promotes rapid development of the company. Qianhui has been granted as Shandong specialization, refinement, specificity and novelty SMEs, Shandong gazelle enterprise. Activing in Industry-University-Research cooperation, Qianhui has co-established China cyclodextrin application and research center with China Pharmaceutical University, and National Key Food Lab of Zibo Cyclodextrin Center with Jiangnan University.
Since 2017 to 2020, Qianhui had undertaken the sub-project of Shandong Province self-created area, sub-project of the national science and technology major special project of new drug creation and development, projects of Double Ten science and technology plan of Zibo City, key special project of MOST “Science and Technology Boosts Economy 2020” etc.
Owning scientific and complete product structure, Qianhui has formed natural α、β、γ cyclodextrin and its derivatives serialization cyclodextrin products. All of the products have been widely used in various fields. With the excellent product quality and the management philosophy of “Be grateful to customers, thinking what customers think, meeting what customers demand”, we set up Qianhui brand in pharmaceutials, food & cosmetics fields. Our products have been exported to Europe, North America, South America,Central and South Asia , Middle East and other regions successfully.
Based on the devoting of product development, keeping researching compounding technology, providing comprehensive cyclodextrin application technology solutions, we are satisfying customers and helping them to achieve the maximum value with excellent products and complete service.
“Stand century-old Qianhui, Do the best excipients” is the eternal mission of Qianhui people!
Completed Stories!
WE DO AWESOME CONTRIBUTE FOR OUR CLIENTS.
1900
Year
Established
0
+
Patent
4900
+
Production Capacity
120
+
Oversea Market
2020
★ Awarded with Shandong Province Gazelle Enterprise
★Shandong Province “Specialized, Excellent, Unique and New” Enterprise
★ Honored with Prominent Financial Contribution Award
★ Obtained Kosher Certification
2019
★ Injectable hydroxypropyl-beta-cyclodextrin was registered at CDE
★Obtained Halal Certification
2018
★ Hydroxypropyl-beta-cyclodextrin completed DMF registration at U.S. FDA
★ Hydroxypropyl-beta-cyclodextrin completed DMF registration at U.S. FDA
★ Undertook the 2nd Cyclodextrin Academic Summit Forum in China
2017
The company passed ISO9001:2015 Quality Management System Certification
2016
★ Sulfobutyl ether beta cyclodextrin sodium obtained domestic clinical approval
★ Obtained national high-tech enterprise
★ Hosted the 1st Cyclodextrin Academic Summit Forum in China
★ Annual Output of 1,000 t Cyclodextrin Derivative Project was put into operation
2015
★Sodium sulfobutyl beta cyclodextrin is registered with the FDA for DMF
★(2015-2017) The company was rated as one of the top 30 high-growth enterprises in Zibo High-tech Zone for three consecutive years
★The company has passed the SGS certification system and obtained the supplier evaluation certificate
2014
Sulfobutabeta cyclodextrin sodium application for clinical application
2013
Independent research and development of sulfobutyl beta cyclodextrin sodium
2012
Hydroxypropyl beta cyclodextrin obtained the registration certificate for pharmaceutical excipients
2011
Obtained the drug production license issued by the State Food and Drug Administration
2010
Establish GMP production workshop
2006
Qianhui was established
- QUALIFICATION HONOR -